Friday 4/21 Insider Buying Report: JPM, AERI Friday, April 21, 10:31 AM ET
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At JPMorgan Chase (JPM), a filing with the SEC revealed that on Wednesday, Director James S. Crown bought 11,500 shares of JPM, at a cost of $85.48 each, for a total investment of $982,991. JPMorgan Chase is trading off about 0.1% on the day Friday.
And at Aerie Pharmaceuticals (AERI), there was insider buying on Wednesday, by Director Gerald D. Cagle who bought 2,000 shares at a cost of $41.70 each, for a trade totaling $83,400. This purchase marks the first one filed by Cagle in the past twelve months. Aerie Pharmaceuticals is trading down about 0.5% on the day Friday. Cagle was up about 2.2% on the buy at the high point of today's trading session, with AERI trading as high as $42.60 at last check today.
For MarketNewsVideo.com, I'm Sayoko Murase.
|